en
Professional article
Open access
English

Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy

Published inJournal of clinical oncology, vol. 20, no. 5, p. 1398-1404
Publication date2002
Abstract

In patients with head and neck cancer enrolled onto a prospective study of positron emission tomography (PET), pretreatment 2-[(18)F] fluoro-2- deoxy-D-glucose (FDG) uptake was evaluated as a predictor of local control and disease-free survival (DFS) after treatment by radiotherapy (RT) with or without chemotherapy.

Keywords
  • Adult
  • Aged
  • Aged
  • 80 and over
  • Antineoplastic Agents/administration & dosage
  • Cisplatin/administration & dosage
  • Disease-Free Survival
  • Female
  • Fluorodeoxyglucose F18/diagnostic use
  • Head and Neck Neoplasms/mortality/therapy
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Prospective Studies
  • Radiopharmaceuticals/diagnostic use
  • Tomography
  • Emission-Computed
  • Treatment Outcome
Citation (ISO format)
ALLAL, Abdelkarim Said et al. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. In: Journal of clinical oncology, 2002, vol. 20, n° 5, p. 1398–1404. doi: 10.1200/JCO.20.5.1398
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0732-183X
681views
421downloads

Technical informations

Creation10/10/2012 7:44:00 PM
First validation10/10/2012 7:44:00 PM
Update time03/14/2023 8:00:56 PM
Status update03/14/2023 8:00:56 PM
Last indexation01/16/2024 1:06:53 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack